The biopharma industry was certainly not immune to the turbulence brought about by the COVID-19 pandemic. The pandemic disrupted — and in some...
Read more
Articles
Viral Clearance Studies for Gene Therapies—Easier Said Than Done
While incidents of biotherapeutic viral contamination have occurred, due to well-established knowledge of the potential sources of contamination and procedures to prevent...
Gene and Cell Therapy Developers Are Getting Creative to Keep Programs on Track During the Pandemic
Jeanette Young, senior consultant for analytical services at BioTechLogic talks with Tonia Becker, Life Sciences Editor, Macon Raine As it became clear that the COVID-19...
Lessons from the Pandemic and Addressing Gene Therapy Process Development Challenges
It’s a fascinating time to be in the biotherapeutics industry. What will the remarkedly rapid COVID-19 vaccine development effort teach us about how to develop and scale...
Lessons and Insights into the Korean Biopharmaceutical Market During the COVID-19 Pandemic
Tonia Becker, Life Sciences Editor, Macon Raine talks with BioTechLogic’s Dr. Eileen Choi How is the COVID-19 pandemic affecting the global biopharmaceutical market?...
Biopharmaceutical Developers Tackle COVID-19 Pandemic-Inflicted Challenges
Tonia Becker, Life Sciences Editor, Macon Raine, talks with BioTechLogic’s Dr. Mike Berry. Knowing that BioTechLogic’s team of biopharmaceutical consultants is working...
